|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net loss | |||||
| Adjustments required to reconcile net loss to net cash used in operating activities: | |||||
| Amortization | |||||
| Stock-based compensation | |||||
| Accounts payable | |||||
| Deferred compensation | |||||
| Unreimbursed expenses (accrued) | |||||
| Net cash used in operating activities | |||||
| Sale of common stock via ATM program, net of costs | |||||
| Net proceeds from exercise of remaining underwriter warrants | |||||
| Sale of common stock via Private Placement, net of costs | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash | |||||
| Cash, beginning of period | |||||
| Cash, end of period | |||||
Loading...